Cystic fibrosis-related diabetes testing in Foggia
Find health labs to test for Cystic fibrosis-related diabetes in Foggia and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Diabetes Test by Igea Piedimonte Srl
SP331, 81016 Piedimonte Matese CE, Italia
61 km
Diabetes Test by PoliSan Laboratorio Analisi Cliniche
Via Ponte Nove Luci, 16, 85100 Potenza PZ, Italia
58.5 km
Hemoglobin Test by Analisi Cliniche La Salute (Laboratorio e Diabetologia)
Via Salvatore Gargiulo, 38, 84086 Roccapiemonte SA, Italia
65.6 km
Hemoglobin Test by Clinica San Michele
Via Montella, 16, 81024 Maddaloni CE, Italia
67 km
Hemoglobin Test by Centro Analisi Cliniche San Paolo
Piazza Europa, 70132 Bari BA, Italia
72.6 km
Verified
A Diabetes Test costs €40.00
See Details
Diabetes Test by Ce.Di.P. Centro Diagnostico Polispecialistico S. Alfonso
Via Filettine, 2, 84016 Pagani SA, Italia
69.3 km
Hemoglobin Test by Farmacia Calò
Via Alessandro Manzoni, 183, 70122 Bari BA, Italia
72.6 km
Hemoglobin Test by GVM - Ospedale Santa Maria
Via Antonio de Ferraris, 22, 70124 Bari BA, Italia
72.6 km
Diabetes Test by Laboratorio di analisi cliniche Cusmai
Via Demetrio Marin, 3, 70125 Bari BA
72.6 km
Unverified
A Diabetes Test costs €35.00
See Details
Diabetes Test by Laboratorio di analisi cliniche Cusmai
Via Demetrio Marin, 3, 70125 Bari BA, Italia
72.6 km
Unverified
A Diabetes Test costs €35.00
See Details
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
